The Effects of Human PEX,a C-terminal Hemopexin-like Domain of MMP-2,on the Growth and Metastasis of Human Breast Cancer BICR-H1 Cells

ZHAO Wei,HAN Hai-bo,ZHANG Zhi-qian
2011-01-01
Abstract:Objective:This study was designed to express human MMP-2 C-terminal hemopexin-like domain(PEX) in E.coli,and then to test its biological effects on angiogenesis,as well as on the growth and metastasis of human breast cancer BICR-H1 cells.Method:PEX was cloned into prokaryotic expression vector pET28a(+) and was induced to express in BL21(DE3)-pLys by IPTG.PEX-His fusion protein,which existed in the inclusion bodies,was denatured by urea method,then was renatured and purified though Ni-NTA agarose beads.The purified PEX-His was further characterized for its biological effects on angiogenesis inhibition,as well as on the suppression of the growth and metastases of human breast cancer BICR-H1 cells by employing the CAM assay.Results: Human PEX expressed in E.coli was able to inhibit the growth of human umbilical vein endothelial cells in a time and dose dependent manner,and could effectively inhibit the CAM angiogenesis.Furthermore,the growth and metastases of BICR-H1 cells were suppressed significantly by injection of 10μg PEX through the vein of chicken embryos,and they were completely disappeared when 30μg PEX was administrated.Conclusion: Human PEX expressed in E.coli is an effective angiongenesis inhibitor.It can inhibit the growth and metastases of BICR-H1 cells,and it might be useful in the treatment of angiongenesis associated diseases such as cancer.
What problem does this paper attempt to address?